Table 2. Correlation of lgr5 methylation with clinicopathological features of colorectal cancer patients.
Clinicopathological feature | n | Lgr5 methylation (%) | χ2 | p |
---|---|---|---|---|
Total | 169 | 67 (40%) | ||
Gender | ||||
Female | 68 | 30 (44%) | 0.951 | 0.341 |
Male | 101 | 37 (37%) | ||
Age (years) | ||||
≥ 60 | 75 | 27 (36%) | 0.749 | 0.431 |
< 60 | 94 | 40 (43%) | ||
Tumor position | ||||
Rectum | 109 | 45 (41%) | 4.899 | 0.179 |
Left colon | 19 | 4 (21%) | ||
Transverse colon | 19 | 6 (32%) | ||
Right colon | 23 | 12 (52%) | ||
Dukes stage | ||||
A | 51 | 21 (33%) | 5.618 | 0.132 |
B | 56 | 27 (36%) | ||
C | 31 | 12 (39%) | ||
D | 31 | 7 (25%) | ||
Tumor grade | ||||
High | 85 | 47 (31%) | 18.84 | <0.001 |
Moderate | 52 | 15 (38%) | ||
Low | 32 | 5 (16%) | ||
Nodal status | ||||
Positive | 31 | 12 (17.9%) | 0.014 | 0.04 |
Negative | 138 | 55(39%) | ||
Distal metastasis | ||||
Positive | 31 | 7 (25%) | 4.620 | 0.024 |
Negative | 138 | 60(51.1%) |
Note: p value was calculated using Pearson’s χ2 test.